John A. Jenkins

Articles by this author

Emergent Biosolutions, Insider Trading, and the Gemba Shuffle

FOIAengine: Media Requests Were Warnings, Months Before Bad News Hit In the early days of the Covid pandemic, there was big money on the line as pharmaceutical companies scrambled to...

How Hedge Funds Use FOIA to Stay Ahead of...

FOIAengine: Warning Letters and Inspection Reports in the Spotlight Freedom of Information Act requests filed with the Food and Drug Administration by hedge funds last month revealed big financial players...

Media’s FOIA Requests Target FDA Gaps

FOIAengine: Growing Scrutiny of Drug Safety and Enforcement  As GLP-1 weight-loss drugs surge in popularity, major news organizations are pressing the Food and Drug Administration for internal records that reveal...

How Capitol Forum Sweeps Up FOIA Data

FOIAengine: The Investigative Outlet Gets Active at the FDA Capitol Forum may be one of the more under-the-radar journalistic enterprises in Washington, but recently it was easily the most active...

The Big Short Goes Long

FOIAengine: “Cassandra Unchained” Plays to Fear and Greed  Michael Burry, the reclusive contrarian who foresaw the 2007 subprime collapse and became the reluctant hero of The Big Short, has walked...

MMTLP Investors Question SEC’s FOIA Denials

FOIAengine: SEC’s$2.5 Billion Outsourcing Contract Explained  The Securities and Exchange Commission, which signed a staffing contract potentially worth $2.5 billion with a Texas-based Alaska Native corporation, appears to have relied...